Applicability domain-expansion studies for machine learning models reveal new inhibitors of CYP2B6

CYP2B6 is an important enzyme in the phase 1 metabolism of key pharmaceuticals, and inhibition of this enzyme can lead to adverse drug events. Machine learning models can potentially predict interactions with CYP2B6; however, there is limited data with which to train these models in the public domai...

Celý popis

Podrobná bibliografia

Vydané v:	Drug metabolism and disposition Ročník 53; číslo 10; s. 100160
Hlavní autori:	Vignaux, Patricia A, Harris, Joshua S, Urbina, Fabio, Ekins, Sean
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Netherlands 01.10.2025
Predmet:	Cytochrome P-450 CYP2B6 - metabolism Humans Machine Learning t-SNE CYP2B6 Applicability domain Drug–drug interaction Machine learning
ISSN:	1521-009X, 1521-009X
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!